Financial, consumer and pharma stocks to drive market over next 2 years: Mahesh Patil
The midcap index has started to relatively outperform a bit but it is still early days.
Share market update: Pharma shares gain; Glenmark Pharma up 2%
The Nifty Pharma index was trading 0.32 per cent up at 7985.8 .
Buy Sun Pharmaceutical Industries, target Rs 455: Kunal Bothra
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 455.0 and a sto...
Most foreign funds not massively overweight on India: Ayon Mukhopadhyay, IIFL Securities
Reforms in the NBFC sector can increase the GDP by 1 to 2%, says Mukhopadhyay.
Why this fund manager is betting against consumption
We are cautious on the consumer space, where we think valuations are stretched specifically with the consumer staples pack. Between the consumer staples and consumer discretionary pack, there is still some upside left on the consumer discretionary side. But we are fairly cautious on the staples pack. On the consumption basket, we continue to be cautious on the auto sector.
Share market update: Nifty Pharma index up; Glenmark Pharma rises 2%
The Nifty Pharma index was trading 0.91 per cent up at 8040.65 .
Dr Reddy's Labs launches generic injection indicated for abortion in US
The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said in a filing to BSE.
Amit Rajan on why pharma MNCs are beating Indian counterparts
Patent protection, ban on fixed dose combinations among factors helping pharma MNCs
Hemang Jani on why telecom, pharma & penny stocks are showing momentum now
FMCG, some private sector banks and even metal names are seeing corrections.
Biocon sees a sweet spot with its affordable insulin in US
The biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologics is chasing a revenue target of $1 billion in financial year 2021-22. In the previous fiscal year, its revenue had topped $200 million.
20 firms turned around in Q2! Are they compelling ‘buy’ ideas now?
Seventeen of these 20 stocks posted up to 51 per cent YoY rise in net sales for the quarter.
E-pharmacies await govt to release regulations for the sector
"We want India to come up with a progressive e-pharmacy regulation. We want that as that would give a lot of clarity and confidence to the sector, whether it is investors, whether it is our business partners and vendors," 1mg Technologies Founder and CEO Prashant Tandon told reporters here. The government is yet to release the final notification.
Metal, pharma, and private banks to give alpha returns as economy turns around: Ajay Srivastava
Economic policies of the government, global flows are marching together and taking the index up
Volume with low cost is Biocon Biologics’ big plan
The Biocon subsidiary will chart a path that ensures high volumes and low costs, unlike competitors. The company plans to create an ecosystem where patients not only have access to the right medicine, but also gets the right care without always reaching a hospital.
Credit Suisse’s Sumit Jalan on why Indian QIP market is booming
This year, the QIPs on an average has been of a significantly higher size.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service